Status
Conditions
Treatments
About
This study is designed as a single center, non blinded, randomized controlled, dual arm trial. We designed to allocate participants in a 1:1 ratio to compare the effects of real-time remote rehabilitation and self rehabilitation with multiple components on muscle strength, muscle mass, balance, and walking ability in patients with sarcopenia. Each participant signs an informed consent form before registering for the study. This protocol follows the 2013 Standard Protocol Project: Intervention Trial Recommendation Guidelines.
Full description
This study is designed as a single center, non blinded, randomized controlled, dual arm trial. We designed to allocate participants in a 1:1 ratio to compare the effects of real-time remote rehabilitation and self rehabilitation with multiple components on muscle strength, muscle mass, balance, and walking ability in patients with sarcopenia. Each participant signs an informed consent form before registering for the study. This protocol follows the 2013 Standard Protocol Project: Intervention Trial Recommendation Guidelines.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
According to the diagnostic criteria for sarcopenia established by the Asian Working Group for Sarcopenia (AWGS):
Low muscle strength:
Handgrip strength < 28 kg for men, < 18 kg for women; and/or
Low physical performance:
Usual gait speed (6-Meter Gait Speed, 6MGS) ≤ 1.0 m/s; and/or
Low muscle mass:
Skeletal Muscle Mass Index (SMI) < 7.0 kg/m² for men, < 5.7 kg/m² for women.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
104 participants in 2 patient groups
Loading...
Central trial contact
Kexin Wang, MM; Linbo Peng, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal